Skip to main navigation
Arvinas logo
Search
Close
Arvinas logo
Search
Close

Investors and Media

Financials and SEC Filings

Annual Reports
2022 Annual Report
2021 Annual Report
2020 Annual Report
2019 Annual Report

Proxy Statements

Filing date View
Apr 28, 2023 View HTML
0001655759-23-000034.pdf
0001655759-23-000034.rtf
0001655759-23-000034.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Apr 27, 2022 View HTML
0001655759-22-000006.pdf
0001655759-22-000006.rtf
0001655759-22-000006.xls

Form 10-K

Filing date View
Feb 23, 2023 View HTML
0001655759-23-000010.pdf
0001655759-23-000010.rtf
0001655759-23-000010.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 28, 2022 View HTML
0001628280-22-004262.pdf
0001628280-22-004262.rtf
0001628280-22-004262.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Form 10-Q

Filing date View
May 05, 2023 View HTML
0001655759-23-000041.pdf
0001655759-23-000041.rtf
0001655759-23-000041.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Nov 09, 2022 View HTML
0001655759-22-000054.pdf
0001655759-22-000054.rtf
0001655759-22-000054.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

All SEC Filings

There are no SEC filings available.

Data provided by Kaleidoscope.

  • Print Page
    Print Page
  • RSS Feeds
    RSS Feeds
  • Email Alerts
    Email Alerts
  • Search
    Search
Arvinas logo
  • Careers
  • Privacy Policy
  • Terms of Use
Menu
  • Careers
  • Privacy Policy
  • Terms of Use
Linkedin-in Twitter

© 2023 Arvinas. All rights reserved.

Arvinas logo
Search
Close
  • Our Science
    • PROTAC® Discovery Engine
    • Scientific Publications
    • Partnerships
  • About Us
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline and Research
    • Pipeline
    • Bavdegalutamide
    • Vepdegestrant
    • Nueroscience
  • Careers and Culture
    • Open Positions
    • Life in the Haven
    • Our Values
    • Benefits
    • Giving Back
  • Patients
    • Patients with Breast Cancer
    • Patients with Prostate Cancer
    • Clinical Trials
    • Expanded Access Policy
  • Investors and Media
    • Press Releases
    • Events and Presentations
    • Corporate Governance
    • Financials and SEC Filings
    • Annual Meeting
    • Stock Information
    • Analyst Coverage
    • Investor FAQs
    • Resources
    • Email Alerts
  • Contact Us
Menu
  • Contact Us
Linkedin-in Twitter